Cargando…

Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer

Background: Doxorubicin (Dox) is one of the most effective chemotherapy agents used in the treatment of solid tumors and hematological malignancies. However, it causes dose-related cardiotoxicity that may lead to heart failure in patients. Luteolin (Lut) is a common flavonoid that exists in many typ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Youyang, Li, Feifei, Shen, Man, Sun, Chenpin, Hao, Wei, Wu, Chunyu, Xie, Ying, Zhang, Shuai, Gao, Hongzhi, Yang, Jianfeng, Zhou, Zhongyan, Gao, Dongwen, Qin, Yuenong, Han, Xianghui, Liu, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548634/ https://www.ncbi.nlm.nih.gov/pubmed/34722681 http://dx.doi.org/10.3389/fcvm.2021.750186

Ejemplares similares

Extract of Platycodon grandiflorum Prevents Doxorubicin-induced Cardiotoxicity in Breast Cancer
por: Shi, Youyang, et al.
Publicado: (2023)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Luteolin alleviates post‐infarction cardiac dysfunction by up‐regulating autophagy through Mst1 inhibition
por: Hu, Jianqiang, et al.
Publicado: (2015)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway
por: Li, Feifei, et al.
Publicado: (2022)

Platycodon grandiflorum Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
por: Hao, Wei, et al.
Publicado: (2020)

Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice
por: Wu, Chunyu, et al.
Publicado: (2022)

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
por: Xu, Haixia, et al.
Publicado: (2020)

Osthole inhibits bone metastasis of breast cancer
por: Wu, Chunyu, et al.
Publicado: (2017)

Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
por: Lu, Chuanwen, et al.
Publicado: (2012)

Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
por: Agostinucci, Kevin, et al.
Publicado: (2022)

The antitumour effect of galangin and luteolin with doxorubicin on chemically induced hepatocellular carcinoma in rats
por: Atwa, Gamal, et al.
Publicado: (2021)

Luteolin prevents uric acid-induced pancreatic β-cell dysfunction
por: Ding, Ying, et al.
Publicado: (2014)

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

Bibliometric and visual analysis of coronary microvascular dysfunction
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Noncardiac anomalies in children with congenital heart disease
por: Huang, Xianghui, et al.
Publicado: (2023)

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019)

Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence
por: Pan, Qinyuan, et al.
Publicado: (2022)

Chronic intermittent hypoxia accelerates cardiac dysfunction and cardiac remodeling during cardiac pressure overload in mice and can be alleviated by PHD3 overexpression
por: Xu, Xuan, et al.
Publicado: (2022)

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
por: Hou, Kai, et al.
Publicado: (2021)

Cardiac vagal dysfunction and myocardial injury after non-cardiac surgery: a planned secondary analysis of the measurement of Exercise Tolerance before surgery study
por: Abbott, T.E.F., et al.
Publicado: (2019)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease
por: Murphy, Jiayuan, et al.
Publicado: (2022)

Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway
por: Zhang, YanDong, et al.
Publicado: (2020)

Chemotherapy-Related Cardiac Dysfunction: Quantitative Cardiac Magnetic Resonance Image Parameters and Their Prognostic Implications
por: Kim, Jinhee, et al.
Publicado: (2023)

Commentary: Sulfur Dioxide Contributes to the Cardiac and Mitochondrial Dysfunction in Rats
por: Chirumbolo, Salvatore, et al.
Publicado: (2016)

Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction
por: Ranjan, Prabhat, et al.
Publicado: (2021)

The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
por: Foulkes, Stephen, et al.
Publicado: (2020)

Dehydrocostus Lactone Enhances Chemotherapeutic Potential of Doxorubicin in Lung Cancer by Inducing Cell Death and Limiting Metastasis
por: Sheng, Wei, et al.
Publicado: (2018)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Luteolin suppresses lipopolysaccharide-induced cardiomyocyte hypertrophy and autophagy in vitro
por: Li, Xing, et al.
Publicado: (2019)

The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction
por: Li, Jiawen, et al.
Publicado: (2021)

Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
por: Xiao, Huiyu, et al.
Publicado: (2021)

Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca(2+)-ATPase 2a
por: Hu, Wenjing, et al.
Publicado: (2017)

Mitochondrial transplantation ameliorates doxorubicin-induced cardiac dysfunction via activating glutamine metabolism
por: Sun, Xiaolei, et al.
Publicado: (2023)

Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1
por: Wang, Shu-hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4dmk2579ruqfephi2f29nui94n